| Code | 3593E | ||||||||||
| MA number | 26/0060/23-S | ||||||||||
| Product Form: | con inf 1x16,7ml/300 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | colourless glass vial (type 1), rubber stopper (type 1) | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 01.06.2023 |
| Validity: | 01.06.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Posaconazole MSN 300 mg_05_2023.pdf
|
| SPC: |
SPC_Posaconazole MSN 300 mg_05_2023.pdf
|
| Safety feature | Yes |
| Data update: | 07.06.2023 |
